Relationship between ultrasonically nebulized distilled water-induced bronchoconstriction and acetic acid-induced cough in asthmatic children. 1995

H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
Department of Pediatrics, Gunma University School of Medicine, Maebashi, Japan.

BACKGROUND Although wheezing and cough are the most common complaints in asthmatic persons, the mechanisms of hyperresponsiveness to bronchoconstriction and cough are nevertheless still unclear. OBJECTIVE To investigate the common mechanisms between them, we studied the relationship between ultrasonically nebulized distilled water (UNDW) inhalation challenge and acetic acid (AA) inhalation challenge. In addition, we evaluated the effect of inhaled furosemide on both provocation tests by means of a placebo-controlled study. METHODS In study 1 the UNDW, AA, and histamine inhalation challenges were performed in 40 asthmatic children (26 boys, aged from 7 to 16 years; mean +/- SD, 11.2 +/- 2.0 years). In study 2, 12 of the study 1 subjects (9 boys, 11.3 +/- 2.4 years) were subjected to each challenge test after inhalation of furosemide (10 mg/body square meters), or placebo (0.9% saline solution) on separate days. RESULTS There was a good correlation between the provocative dose causing a 20% fall in forced expiratory volume in 1 second in the UNDW inhalation challenge (UNDW-PD20) and threshold dose causing cough in the AA inhalation challenge (R = 0.527; p < 0.001). There was no relationship either between UNDW-PD20 and the provocative concentration causing a 20% fall in the histamine inhalation challenge (histamine-PC20)(R = 0.384; p > 0.1), or between histamine-PC20 and the cough threshold (R = 0.308; p > 0.05). In study 2 neither bronchoconstriction nor bronchodilation after inhalation of furosemide was observed. Inhaled furosemide exerted a protective effect on UNDW-PD20 and cough threshold of the AA inhalation challenge (p < 0.01 and p < 0.01, respectively), but did not attenuate histamine-PC20 (p > 0.1). CONCLUSIONS These data suggest that a common mechanism may cause hyperresponsiveness against both UNDW-induced bronchoconstriction and AA-induced cough in asthmatic children.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003371 Cough A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs. Coughs
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
October 1997, The European respiratory journal,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
February 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
July 1988, Annals of allergy,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
October 1998, British journal of pharmacology,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
July 1989, The American review of respiratory disease,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
January 2000, Prostaglandins & other lipid mediators,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
May 1989, Chest,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
February 1994, Annals of allergy,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
April 1994, Clinical trials and meta-analysis,
H Mochizuki, and T Shimizu, and S Maeda, and K Tokuyama, and A Morikawa, and T Kuroume
October 1992, The American review of respiratory disease,
Copied contents to your clipboard!